Management of acute coronary syndromes during the COVID-19 outbreak in Lombardy: The ‘‘macro-hub” experience q

Authorities of Lombardy modified the regional network concerning time-dependent emergencies. Specifically, 13 Macro-Hubs were identified to deliver timely optimal care to patients with acute coronary syndromes (ACS). Aim of this paper is to present the results of this experience. Methods and Results: This is a multicenter, observational study. A total of 953 patients were included, pre- senting with STEMI in 57.7% of the cases. About 98% of patients received coronary angiography with a median since first medical contact to angiography of 79 (IQR 45–124) minutes for STEMI and 1262 (IQR 643–2481) minutes for NSTEMI. A total of 107 patients (11.2%) had SARS-CoV2 infection, mostly with STEMI (74.8%). The time interval from first medical contact to cath-lab was significant shorter in patients with COVID-19, both in the overall population and in STEMI patients (87 (IQR 41–310) versus 160 (IQR 67–1220) minutes, P = 0.001, and 61 (IQR 23–98) versus 80 (IQR 47–126) minutes, P = 0.01, respectively). In-hospital mortality and cardiogenic shock rates were higher among patients with COVID-19 compared to patients without (32% vs 6%, P < 0.0001, and 16.8% vs 6.7%, P < 0.0003, respectively). Conclusions: During the COVID-19 outbreak in Lombardy, the redefinition of ACS network according to enlarged Macro-Hubs allowed to continue with timely ACS management, while reserving a high number of intensive care beds for the pandemic. Patients with ACS and COVID-19 presented a worst outcome, particularly in case of STEMI.

[1]  Z. Siudak,et al.  Clinical and procedural characteristics of COVID‐19 patients treated with percutaneous coronary interventions , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  M. Hauguel-Moreau,et al.  Impact of Coronavirus Disease 2019 outbreak on acute coronary syndrome admissions: four weeks to reverse the trend , 2020, Journal of Thrombosis and Thrombolysis.

[3]  R. de Caterina,et al.  Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era , 2020, European heart journal.

[4]  Susanna Price,et al.  EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic , 2020, European heart journal.

[5]  M. Metra,et al.  Centralization of the ST elevation myocardial infarction care network in the Lombardy region during the COVID-19 outbreak , 2020, International Journal of Cardiology.

[6]  B. Ibáñez,et al.  The Obstacle Course of Reperfusion for ST-Segment–Elevation Myocardial Infarction in the COVID-19 Pandemic , 2020, Circulation.

[7]  Qing Zhou,et al.  Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China , 2020, International Journal of Cardiology.

[8]  Jie Zeng,et al.  How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s Hospital , 2020, Intensive Care Medicine.

[9]  B. Gersh,et al.  The organization, function, and outcomes of ST-elevation myocardial infarction networks worldwide: current state, unmet needs and future directions. , 2014, European heart journal.